Sign in
4

Changes in Ownership

ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000042

CEO bought 59,700 shares at an average $0.02 ($921)

From the SEC's structured data for this filing

Trades in this filing

Collier Alan Brian · CEO

Table I: Non-derivative

10 lines
Date Transaction Shares Price Value Owned after D/I
2019-07-10 Purchase : show line 1 in the form +5,000 $0.02 $79 24,708,097 D
2019-07-10 Purchase : show line 2 in the form +2,000 $0.02 $31 24,710,097 D
2019-07-10 Purchase : show line 3 in the form +20,000 $0.02 $310 24,730,097 D
2019-07-10 Purchase : show line 4 in the form +15,000 $0.02 $228 24,745,097 D
2019-07-10 Purchase : show line 5 in the form +5,000 $0.02 $76 24,750,097 D
2019-07-10 Purchase : show line 6 in the form +5,000 $0.02 $78 24,755,097 D
2019-07-10 Purchase : show line 7 in the form +2,000 $0.02 $30 24,757,097 D
2019-07-10 Purchase : show line 8 in the form +5,000 $0.02 $79 24,762,097 D
2019-07-11 Purchase : show line 9 in the form +500 $0.02 $8 24,762,597 D
2019-07-11 Purchase : show line 10 in the form +200 $0.02 $3 24,762,797 D
Open-market purchases · 59,700 sh · avg $0.02 · $921
Loading xslF345X03/primary_doc.xml…